KK Shah Hospitals Board of Directors

Get the latest insights into the leadership at KK Shah Hospitals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Amit Shah Chairman & Managing Director
Mr. Kirti Kumar Shah Whole Time Director
Mrs. Hansa Shah Executive Director
Mrs. Milli Shah Executive Director
Mr. Achint Porwal Ind. Non-Executive Director
Mr. Gaurav Ajmera Ind. Non-Executive Director
Mr. Meetesh Gadia Ind. Non-Executive Director
Ms. Sanjay Kumar Luniya Ind. Non-Executive Director

KK Shah Hospitals Share price

KKSHL

47

0.00 (0.00%)
Last updated on 4 Sep, 2025 | 12:06 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

31.60

52 Week High

54.95

The current prices are delayed, login to your account for live prices

KK Shah Hospitals FAQs

The board at KK Shah Hospitals consists of experienced professionals, including Mr. Amit Shah , Mr. Kirti Kumar Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at KK Shah Hospitals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Amit Shah is the current chairman at KK Shah Hospitals.

Executive directors at KK Shah Hospitals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, KK Shah Hospitals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At KK Shah Hospitals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.